Cargando…
Antitrypanosomal Activity of 1,2,3-Triazole-Based Hybrids Evaluated Using In Vitro Preclinical Translational Models
SIMPLE SUMMARY: Chagas disease, caused by the protozoan Trypanosoma cruzi, is a neglected tropical disease that affects 6–7 million people worldwide. It is a global disease, due to migration from Latin America to other regions of the world, and a recognized worldwide public health problem. Clinical...
Autores principales: | Orlando, Lorraine Martins Rocha, Lara, Leonardo da Silva, Lechuga, Guilherme Curty, Rodrigues, Giseli Capaci, Pandoli, Omar Ginoble, de Sá, Druval Santos, Pereira, Mirian Claudia de Souza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525445/ https://www.ncbi.nlm.nih.gov/pubmed/37759621 http://dx.doi.org/10.3390/biology12091222 |
Ejemplares similares
-
Bioactivity of Novel Pyrazole-Thiazolines Scaffolds against Trypanosoma cruzi: Computational Approaches and 3D Spheroid Model on Drug Discovery for Chagas Disease
por: Lara, Leonardo da Silva, et al.
Publicado: (2022) -
Synthesis, study of antileishmanial and antitrypanosomal activity of imidazo pyridine fused triazole analogues
por: Nandikolla, Adinarayana, et al.
Publicado: (2020) -
Structural Optimization and Biological Activity of Pyrazole Derivatives: Virtual Computational Analysis, Recovery Assay and 3D Culture Model as Potential Predictive Tools of Effectiveness against Trypanosoma cruzi
por: Orlando, Lorraine Martins Rocha, et al.
Publicado: (2021) -
1,2,3-Triazoles
por: Rachwal, S., et al.
Publicado: (2008) -
Histone deacetylases as targets for antitrypanosomal drugs
por: Zuma, Aline A, et al.
Publicado: (2018)